Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells

Cancer Research

Volumn 57, Issue 10, 1997, Pages 1939-1945

  Walker, Andrew ^a   Taylor, Siân T ^a   Hickman, John A ^a   Dive, Caroline ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN P53; VASCULAR CELL ADHESION MOLECULE 1;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CELL CYCLE; CELL PROLIFERATION; CLONOGENESIS; CONTROLLED STUDY; DNA DAMAGE; DRUG RESISTANCE; GERMINAL CENTER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANTIGENS, CD40; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; BCL-X PROTEIN; CHLORAMBUCIL; CLONE CELLS; DNA DAMAGE; GERMINAL CENTER; HUMANS; LYMPHOMA, B-CELL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0031004077     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Raff, M. C. Social controls on cell survival and cell death. Nature (Lond.), 356: 397-400, 1992.
2. Harrington, E. A., Bennett, M. R., Fanidi, A., and Evan, G. I. c-Myc-induced apoptosis in fibroblasts in inhibited by specific cytokines. EMBO J., 13: 3286-3295, 1994.
3. Collins, M. K., Marvel, J., Malde, P., and Lopez-Rivas, A. Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA-damaging agents. J. Exp. Med., 176: 1043-1051, 1992.
4. Edwards, S. N., Buckmaster, A. E., and Tolkovsky, A. M. The death programme in cultured sympathetic neurons can be suppressed at the post-translational level by nerve growth factor, cyclic AMP, and depolarization. J. Neurochem., 57: 2140-2143, 1991.
5. MacLennan, I. C. M., Liu, Y-J., and Johnson, G. D. Germinal centres in the immune response. Immunol. Rev., 126: 143-161, 1992.
6. Frische, S. M., and Francis, H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol., 124: 619-626, 1994.
7. Pullan, S., Wilson, J., Metcalf, A., Edwards, G. M., Goberdhan, N., Tilly, J., Hickman, J. A., Dive, C., and Streuli, C. H. J. Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium. J. Cell Sci., 109: 631-642, 1996.
8. Reed, J. C. Regulation of apoptosis by bcl-2 family proteins and its role in cancer chemoresistance. Curr. Opin. Oncol., 7: 541-546, 1995.
9. Strasser, A., Harris, A. W., Jacks, T., and Cory, S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell, 79: 329-339, 1994.
10. Miyashita, T., and Reed, J. C. BCL-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood, 81: 151-157, 1993.
11. Kamesaki, S., Kamesaki, H., Jorgensen, T. J., Tanizawa, A., Pommier, Y., and Cossman, J. bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair. Cancer Res., 53: 4251-4256, 1993.
12. Yin, D. X., and Schimke, R. T. BCL-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells. Cancer Res., 55: 4922-4928, 1995.
13. Hickman, J. A. Apoptosis and cancer chemotherapy. Eur. J. Cancer, 32: 921-926, 1996.
14. Clark, E. A., and Ledbetter, J. A. How B and T cells talk to each other. Nature (Lond.), 367: 425-428, 1994.
15. Durie, F. H., Foy, T. M., Masters, S. R., Laman, J. D., and Noelle, R. J. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today, 15: 406-410, 1994.
16. Korsmeyer, S. J. Regulators of cell death. Trends Genet., 11: 101-105, 1995.
17. Liu, Y-J., Joshua, D. E., Williams, G. T., Smith, C. A., Gordon, J., and MacLennan, I. C. M. Mechanisms of antigen driven selection in germinal centres. Nature (Lond.), 342: 929-931, 1989.
18. Banchereau, J., De Paoli, P., Valle, A., Garcia, E., and Rousset, F. Long-term human B cell lines dependent on interleukin 4 and antibody to CD40. Science (Washington DC), 251: 70-72, 1991.
19. Johnson, P. W. M., Watt, S. M., Betts, D. R., Davies, D., Jordan, S., Norton, A. J. C., and Lister, T. A. Isolated lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system. Blood, 82: 1842-1857, 1993.
20. Holder, M. J., Wang, H., Milner, A. E., Casamayor, M., Armitage, R., Spriggs, M. K., Fanslow, W. C., MacLennan, I. C. M., Gregory, C. D., and Gordon, J. Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl-2 induction. Eur. J. Immunol., 23: 2368-2371, 1993.
21. L in CD40-mediated rescue from anti-μ-induced apoptosis in WEHI-231 B lymphoma cells. Eur. J. Immunol., 25: 1352-1357, 1995.
22. Wang, Z., Karros, J. G., Howard, R. G., and Rothstein, T. L. Induction of bcl-x by CD40 engagement rescues sIg-induced apoptosis in murine B cells. J. Immunol., 155: 3722-3725, 1995.
23. Milner, A. E., Johnson, G. D., and Gregory, G. D. Prevention of programmed cell death in Burkitt lymphoma cell lines by BCL-2-dependent and p-independent mechanisms. Int. J. Cancer, 52: 636-646, 1992.
24. Gregory, C. D., Dive, C., Henderson, S., Smith, C. A., Williams, G. T., Gordon, J., and Rickinson, A. B. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature (Lond.), 349: 612-614, 1991.
25. Dive, C., Gregory, C. D., Phipps, D. J., Evans, D. L., Milner, A. E., and Wyllie, A. H. Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim. Biophys. Acta, 1133: 275-285, 1992.
26. Furth, E. E., Thilly, W. G., Penman, B. W., Liber, H. L., and Rand, W. M. Quantitative assay for mutation in diploid human lymphoblasts using microtitre plates. Anal. Biochem., 110: 1-8, 1981.
27. Rohatiner, A. Z., and Lister, T. A. New approaches to the treatment of follicular lymphoma. Br. J. Haematol., 79: 349-354, 1991.
28. Horning, S. J. Treatment approaches to the low-grade lymphomas. Blood, 83: 881-884, 1994.
29. Dive, C., and Hickman, J. A. Drug target interactions: only the first step in the commitment of a cell to a programmed cell death. Br. J. Cancer, 64: 192-196, 1991.
30. Fisher, D. E. Apoptosis in cancer therapy: crossing the threshold. Cell, 78: 539-542, 1994.
31. Pezzella, F., Jones, M., Ralfkiaer, E., Ersboll, J., Gatter, K. C., and Mayson, D. Y. Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma. Br. J. Cancer, 65: 87-89, 1992.
32. Fairbairn, L. J., Cowling, G. J., Reipert, B. M., and Dexter, T. M. Suppression of apoptosis allows differentiation and development of a multipotent haemopoetic cell line in the absence of added growth factors. Cell, 74: 823-832, 1993.
33. L can confer a multidrug resistance phenotype. Blood, 86: 1903-1910, 1995.
34. L and CD40 in WEHI-231 cells. J. Immunol., 155: 3830-3838, 1995.
35. Ishida, T., Kobayashi, N., Tojo, T., Ishida, S., Yamamoto, T., and Inoue, J. CD40 signalling-mediated induction of Bcl-xL, Cdk4 and Cdk6. J. Immunol., 155: 5527-5535, 1995.
36. Fisher, T. C., Milner, A. E., Gregory, C. D., Jackman, A. L., Wynne Aherne, G., Hartley, J. A., Dive, C., and Hickman, J. A. bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res., 53: 3321-3326, 1993.